Kearns Evan

Kearns Evan is listed in filings as Chief Legal Officer at Cogent Biosciences, Inc.. This profile follows SEC Form 4 activity through Dec 30, 2025, including sale activity. Recent filings connect the profile to Cogent Biosciences, Inc. (COGT). The current snapshot covers public activity from Jan 27, 2025 to Dec 30, 2025. Reported amounts are shown as $2.0M to $5.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.